Protalix BioTherapeutics Aktie
WKN DE: A0ML0E / ISIN: US74365A1016
17.03.2025 11:57:03
|
Protalix BioTherapeutics Inc. Reveals Fall In Full Year Bottom Line
(RTTNews) - Protalix BioTherapeutics Inc. (PLX) announced earnings for full year that decreased from the same period last year
The company's earnings totaled $2.93 million, or $0.04 per share. This compares with $8.31 million, or $0.09 per share, last year.
The company's revenue for the period fell 18.5% to $53.40 million from $65.49 million last year.
Protalix BioTherapeutics Inc. earnings at a glance (GAAP) :
-Earnings: $2.93 Mln. vs. $8.31 Mln. last year. -EPS: $0.04 vs. $0.09 last year. -Revenue: $53.40 Mln vs. $65.49 Mln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Protalix BioTherapeutics Incmehr Nachrichten
Keine Nachrichten verfügbar. |